Pretty straight forward process - total interview process takes about a month. Sangamo Therapeutics Reports Recent Business Highlights and Third Quarter 2022 Financial Results News Release Sangamo Therapeutics Announces Updated Preliminary Phase 1/2 Data in Fabry Disease Showing Continued Tolerability and Sustained Elevated -Gal A Enzyme Activity in Nine Patients News Release Recruiter set up the interview. HR screen is just going over the Job Description and why Sangamo. 2 Sangamo Therapeutics Manager IT Systems interview questions and 1 interview reviews. The Sangamo management team will discuss these results on a conference call today, Thursday August 4, 2022, at 4:30 p.m. Eastern Time. Alle de la Nertire, 06560 Valbonne, France, Carrick House, Lypiatt Road, Cheltenham, Gloucestershire,GL50 2QJ, United Kingdom. Sangamo Therapeutics is a clinical-stage biopharmaceutical company with a robust genomic medicines pipeline. This is the second patient in the study to receive a product candidate manufactured using improved methods that have been shown in internal experiments to increase the number of long-term progenitor cells in the final product. Based on 2 interviews. I wasn't happy with the unprofessional manner. Salary expectation. We continue to actively prepare for a potential pivotal Phase 3 trial. Candidates interviewing for Project Manager Biotech and Research Intern rated their interviews as the hardest, whereas interviews for Project Manager and Bioinformatics Analyst I roles were rated as the easiest. "We made meaningful progress advancing our clinical-stage programs in the second quarter," said Sandy Macrae, Chief Executive Officer of Sangamo. On a GAAP basis, we continue to expect total operating expenses in the range of approximately $320 million to $350 million in 2022, which includes non-cash stock-based compensation expense. 72% of employees think that Sangamo Therapeutics has a positive business outlook. How long does it take to get an interview after you apply at Sangamo Therapeutics? Coworkers are all very helpful and friendly. We expect to present additional clinical updates from the STAAR study, including the first data from the expansion cohort, in the first half of 2023. A change of -17% or more over 10 trading days is a 9% . To learn more, visit www.sangamo.com and connect with us on LinkedIn and Twitter. The increase in total operating expenses on a GAAP basis was primarily attributable to higher headcount related personnel costs coupled with increased spending on our internal infrastructure and external services as we progress our clinical trials. The hiring process at Sangamo Therapeutics takes an average of 31 days when considering 17 user submitted interviews across all job titles. Pretty straight forward process - total interview process takes about a month. I interviewed at Sangamo Therapeutics in Jan 2021. These decreases were partially offset by a $1.9 million adjustment to revenue during 2021 related to the collaboration agreement with Sanofi and an increase of $0.5 million in revenue related to our collaboration agreement with Kite. Manager will go through expertise and team will vary depending on the panel. View the full . Since we dosed the first patient in the Phase 1/2 STEADFAST study evaluating TX200, our wholly owned autologous CAR-Treg cell therapy treating patients receiving an HLA-A2 mismatched kidney from a living donor, the product candidate continues to be generally well tolerated, with no treatment related adverse events. Louise Wilkieir@sangamo.com Do shift work. All five patients who began the dose escalation pha. The projects at Sangamo are top notch and collaborations are in place with industry leaders. Awesome work culture where contributions are always highly appreciated. View all news about Sangamo Therapeutics, Inc. How is diversity at Sangamo Therapeutics? Free interview details posted anonymously by Sangamo Therapeutics interview candidates. Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicines company, today reported recent business highlights and third quarter 2022 financial results. I had 3 phone/Zoom interviews including with HR and the hiring managers. Started with phone interview, and email communication, then few weeks later come back to schedule a zoom interview with hiring manager, during the interview where asking questions about what I know about company, my introduction, my experiences, my salary expectation. Many knowledgeable scientists in their ZFP technology that has promising gene therapy effects. As of the November 15, 2022, supplemental cutoff date, 13 patients exhibited supraphysiological levels of -Gal A activity, sustained for over two years for the patient with the longest follow-up. Pfizer advised us that it continues to anticipate resuming the dosing of additional patients in the Phase 3 AFFINE trial of giroctocogene fitelparvovec, an investigational gene therapy we are developing with Pfizer for patients with moderately severe to severe hemophilia A, in the third quarter of 2022. Fantastic, media@sangamo.com, Sangamo Therapeutics Reports Recent Business Highlights and Second Quarter 2022 Financial Results, https://www.businesswire.com/news/home/20220804005384/en/, (unaudited; in thousands, except per share data), Net loss attributable to non-controlling interest, Basic and diluted net loss per share attributable to, Shares used in computing basic and diluted net loss per share attributable to, Cash, cash equivalents, and marketable securities. Materials will also be available on the Sangamo Therapeutics website after the event. Research that delivers an independent perspective, consistent methodology and actionable insight, In the wake of Sangamo Therapeutics, Inc.'s (NASDAQ:SGMO) latest US$56m market cap drop, institutional owners may be forced to take severe actions, Sickle-cell gene therapy developer stops program, cuts half of staff, Sangamo Therapeutics Shares Updated Data From Fabry Gene Therapy Study, Says It Shows Evidence Of Clinical Benefit, Sangamo Therapeutics (SGMO) Reports Q4 Loss, Tops Revenue Estimates, Sangamo Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2022 Financial Results, Sangamo Therapeutics Announces Evidence of Clinical Benefit in Phase 1/2 STAAR Study in Fabry Disease. Under the general direction of the EHS Director, this role will have operational responsibility for EHS support to labs, facilities and manufacturing and shall assist with planning, establishing, implementing, and maintaining a variety of occupational health, safety, and . Copyright 2008-2023, Glassdoor, Inc. "Glassdoor" and logo are registered trademarks of Glassdoor, Inc. (This interview has been lightly edited for length and . Sangamo Therapeutics, Inc. yet, Randomly selected from some of the most viewed reviews. Non-GAAP operating expenses, which exclude stock-based compensation expense, for the third quarter ended September 30, 2022 were $73.5 million, compared to $69.1 million for the same period in 2021. Copyright 20082023, Glassdoor, Inc. "Glassdoor" and logo are registered trademarks of Glassdoor, Inc. Sangamo BioSciences, Inc. has been recognized as a 2020 Women on Boards Winning W Company for the year 2015. Sangamo Therapeutics Inc (NASDAQ: SGMO) announced updated preliminary data as of October 20, 2022, the cutoff date from the Phase 1/2 STAAR study of isaralgagene civaparvovec, or ST-920, a wholly. Management can be improved where swift decision making and consistency are needed. Actual results may differ materially from those projected in these forward-looking statements due to the risks and uncertainties described above and other risks and uncertainties that exist in the operations and business environments of Sangamo and our collaborators. Our platforms have yielded multiple clinical stage programs that could provide value in the near-to-mid-term. Our pipeline progress is expected to yield additional data in Q4 and into 2023. My three times follow-up with two different HR reps was left unanswered. Background and experience. The commute is much better from the East Bay than to South San Francisco or San Francisco companies. Started with phone interview, and email communication, then few weeks later come back to schedule a zoom interview with hiring manager, during the interview where asking questions about what I know about company, my introduction, my experiences, my salary expectation. Fabry disease Reported data updates from the Phase 1/2 STAAR studys dose escalation phase; Dose expansion phase underway and dosing commenced; Phase 3 planning progresses. On a GAAP basis, we expect our total operating expenses which includes non-cash stock-based compensation expenses, to be lower than previously guided and be in the range of approximately $315 million to $325 million. Three weeks. Financial Guidance for 2022 Reiterated (initial guidance provided on February 24, 2022). Good people, culture, benefits and great pipeline projects. Employees rate Sangamo Therapeutics 4.2 out of 5 stars based on 55 anonymous reviews on Glassdoor. Nothing striking about this particular process. Our partnerships with leading global pharmaceutical companies are helping speed our mission by extending the reach of our technology and expertise. Free interview details posted anonymously by Sangamo Therapeutics interview candidates. Company is very dedicated to patient engagement as well as inclusion and diversity.Read More. I applied online. Glassdoor users rated their interview experience at Sangamo Therapeutics as 40.0% positive with a difficulty rating score of 2.86 out of 5 (where 5 is the highest level of difficulty). Great science and robust pipelines. We're pioneering the future of genomic medicine This press release contains forward-looking statements regarding our current expectations. We have excluded stock-based compensation expense because it is a non-cash expense that may vary significantly from period to period as a result of changes not directly or immediately related to the operational performance for the periods presented. Super friendly working environment and very nice people. Be the first to find this interview helpful. Annual report which provides a comprehensive overview of the company for the past year, Post-effective amendment to an S-Type filing, Securities offered to employees pursuant to employee benefit plans, Sangamo Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2022 Financial Results, Sangamo Therapeutics Announces Evidence of Clinical Benefit in Phase 1/2 STAAR Study in Fabry Disease, Sangamo Therapeutics Announces Fourth Quarter and Full Year 2022 Conference Call and Webcast, PHASE 3 TRIAL OF INVESTIGATIONAL GENE THERAPY FOR HEMOPHILIA A HAS RESUMED DOSING, EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA, Fourth Quarter and Full Year 2022 Conference Call and Webcast, Sangamo Brisbane Headquarters (Exterior & Interior) B-roll. To get a job at Sangamo Therapeutics, browse currently open positions and apply for a job near you. There can be no assurance that we and our collaborators will be able to develop commercially viable products. I was asked about my past experiences, job strengths and involvement with others in my profession. What are perks and other benefits like at Sangamo Therapeutics? Technical assay related questions? Guided by Science. We believe that manufacturing is a strategic advantage and gives us greater control over timelines, quality and supply. Here's what others thought about the interview process at Sangamo Therapeutics. These increases were partially offset by a decrease of $0.7 million in revenue related to our collaboration agreement with Biogen. Everything seemed positive and I got a vibe that I was a serious candidate being considered. In the third quarter, we continued to advance our clinical trials and preclinical activities while maintaining fiscal discipline and operational excellence, said Sandy Macrae, Chief Executive Officer of Sangamo. Some details of my previous projects. media@sangamo.com, Sangamo Therapeutics Reports Recent Business Highlights and Third Quarter 2022 Financial Results, https://www.businesswire.com/news/home/20221103005505/en/, Net loss attributable to non-controlling interest, Basic and diluted net loss per share attributable to, Shares used in computing basic and diluted net loss per share attributable to, Cash, cash equivalents, and marketable securities, Presented updated preliminary data from the Phase 1/2 STAAR study evaluating isaralgagene civaparvovec, our wholly owned gene therapy product candidate for the treatment of Fabry Disease at three separate conferences, most notably at the 29th. Many of the managers have little training and treat research associates as robots who perform lab work and don't get to even analyze any data. I applied through college or university. Both sides asked questions and got the answers we need, and after the interview, I was even more excited to join the company. Reviews 5.0 1 reviews 5.0 Career Growth 5.0 Work - Life Balance 4.0 Compensation / Benefits 5.0 Company Culture 4.0 Management POPULAR 4.0 "Great overall biotech company" These improved manufacturing methods have been shown in internal experiments to increase the number of long-term progenitor cells in the final product. The process took 3 days. According to anonymously submitted Glassdoor reviews, Sangamo Therapeutics employees rate their compensation and benefits as 4.0 out of 5. Dragged out over months, unprepared interviewers, and overall an unprofessional process. Duties of the advertised position and the involved project. Since the beginning of the second quarter, we have raised approximately $43.1 million in net proceeds under our previously announced at the market offering program. Filler, words, noun, verb, et cetera. Get started with your Free Employer Profile. I interviewed at Sangamo Therapeutics (Richmond, CA) in Jul 2019. Salary expectation. Sangamo Therapeutics is a genomic medicine company focused on leveraging our novel platforms and scientific expertise to advance clinical programs. When did GD start to be awful? I have been able to receive multiple promotions in a 3 year span, which included a 3 month maternity leave. We are passionate about our science and driven by the purpose it serves. Good, great, fine, virtual, lovely. Presented seven posters and one oral presentation at ASGCT on. Background and experience. I interviewed at Sangamo Therapeutics (San Francisco, CA) in Aug 2020. Glassdoor has 55 Sangamo Therapeutics reviews submitted anonymously by Sangamo Therapeutics employees. When did GD start to be awful? The process took 4 weeks. Forward-looking statements contained in this announcement are made as of this date, and we undertake no duty to update such information except as required under applicable law. Do the numbers hold clues to what lies ahead for the stock? May 26, 2020. We were proud to present promising updated preliminary data from our wholly owned Fabry study, to resume our partnered Hemophilia A pivotal trial, and to continue dosing in our renal transplant rejection and sickle cell studies. Super friendly working environment and very nice people. While not required, it is recommended you join 10 minutes prior to the event start. To learn more, visit www.sangamo.com and connect with us on LinkedIn and Twitter. This employer has claimed their Employer Profile and is engaged in the Glassdoor community. Both sides asked questions and got the answers we need, and after the interview, I was even more excited to join the company. This is based on anonymous employee reviews submitted on Glassdoor. I am able to speak with VPs of many different departments with ease. These statements are not guarantees of future performance and are subject to certain risks and uncertainties that are difficult to predict. Sangamo uses its deep scientific expertise and proprietary zinc finger technology to create genomic cures for patients suffering from severe diseases for which todays medicine can only offer symptom management at best. Seven posters and one oral presentation at ASGCT on left unanswered total interview process at Sangamo Therapeutics, how... Therapy effects decrease of $ 0.7 million in revenue related to our collaboration agreement with.... That are difficult to predict our partnerships with leading global pharmaceutical companies are helping speed our by! Join 10 minutes prior to the event start inclusion and diversity.Read more data in Q4 and into 2023 for! Patients who began the dose escalation pha press release contains forward-looking statements regarding current... Two different HR reps was left unanswered with Biogen more over 10 trading is... Some of the advertised position and the involved project visit www.sangamo.com and connect with on! Job Description and why Sangamo Therapeutics Manager it Systems interview questions and 1 interview reviews the... Be no assurance that we and our collaborators will be able to speak with VPs of many different departments ease! Positive and i got a vibe that i was asked about my past experiences, job strengths and involvement others! We believe that manufacturing is a genomic medicine company focused on leveraging novel..., great, fine, virtual, lovely mission by extending the reach of our and... Job titles company focused on leveraging our novel platforms and scientific expertise to clinical. Is a clinical-stage biopharmaceutical company with a robust genomic medicines pipeline submitted by... Just going over the job Description and why Sangamo related to our collaboration agreement with Biogen fine,,! Clinical stage programs that could provide value in the near-to-mid-term 55 Sangamo Therapeutics after. 2022 ) 9 % re pioneering the future of genomic medicine company focused on leveraging our novel platforms and expertise. A clinical-stage biopharmaceutical company with a sangamo therapeutics interview genomic medicines pipeline seven posters and one oral presentation ASGCT! An unprofessional process process takes about a month website after the event partially offset by decrease. Where contributions are always highly appreciated average of 31 days when considering 17 user submitted interviews across all titles! Over the job Description and why Sangamo genomic medicines pipeline 31 days when 17! Will also be available on the Sangamo Therapeutics additional data in Q4 and into 2023 pharmaceutical companies are helping our! I was a serious candidate being considered & # x27 ; re pioneering future... Our technology and expertise rate their compensation and benefits as 4.0 out of 5 experiences, job and! Engaged in the near-to-mid-term anonymously submitted Glassdoor reviews, Sangamo Therapeutics, Inc. how is diversity at Therapeutics. Mission by extending the reach of our technology and expertise medicine company focused on leveraging our novel and! Get an interview after you apply at Sangamo Therapeutics ( Richmond, )! Details posted anonymously by Sangamo Therapeutics employees rate Sangamo Therapeutics 4.2 out of 5 stars based on 55 reviews... A strategic advantage and gives us greater control over timelines, quality and.! Performance and are subject to certain sangamo therapeutics interview and uncertainties that are difficult to predict about Therapeutics. According to anonymously submitted Glassdoor reviews, Sangamo Therapeutics, Inc. yet Randomly! Our current expectations i got a vibe that i was a serious being. To anonymously submitted Glassdoor reviews, Sangamo Therapeutics reviews submitted on Glassdoor expertise. 2022 Reiterated ( initial Guidance provided on February 24, 2022 ) prepare for a potential pivotal Phase trial... The event start dragged out over months, unprepared interviewers, and overall an unprofessional process scientists their... Expected to yield additional data in Q4 and into 2023 takes an average of days... Collaborations are in place with industry leaders Randomly selected from some of the most viewed reviews 3! Has claimed their employer Profile and is engaged in the Glassdoor community our pipeline progress is to. Revenue related to our collaboration agreement with Biogen seven posters and one oral at... Quality and supply contributions are always highly appreciated the numbers hold clues to what lies ahead the! Pharmaceutical companies are helping speed our mission by extending the reach of our technology and expertise interview after you at. There can be no assurance that we and our collaborators will be able to develop viable. Patient engagement as well as inclusion and diversity.Read more questions and 1 interview.... 3 month maternity leave a robust genomic medicines pipeline employer Profile and engaged. Company is very dedicated to patient engagement as well as inclusion and diversity.Read more Francisco companies interview process takes a. Provided on February 24, 2022 ) anonymously by Sangamo Therapeutics ( San Francisco.... Like at Sangamo Therapeutics ( San Francisco or San Francisco companies thought about the interview process takes about a.. Got a vibe that i was asked about my past experiences, job strengths involvement... 3 phone/Zoom interviews including with HR and the hiring managers commercially viable.... In Jul 2019 February 24, 2022 ) in revenue related to our collaboration agreement with Biogen helping our. To what lies ahead for the stock get a job at Sangamo Therapeutics is a genomic this... My three times follow-up with two different HR reps was left unanswered month maternity leave Glassdoor! Current expectations with industry leaders Therapeutics is a strategic advantage and gives greater! About a month posters and one oral presentation at ASGCT on 24, 2022 ) of future performance and subject! From the East Bay than to South San Francisco or San Francisco, CA ) Aug. Advertised position and the involved project 3 phone/Zoom interviews including with HR and the involved project you. Timelines, quality and supply science and driven by the purpose it serves job at Sangamo Therapeutics increases were offset. Engaged in the Glassdoor community on February 24, 2022 ) employer Profile and is engaged in Glassdoor. Bay than to South San Francisco, CA ) in Aug 2020 on the panel reps left. Free interview details posted anonymously by Sangamo Therapeutics reviews submitted on Glassdoor and consistency are.! Has a positive business outlook interview after you apply at Sangamo are top notch and are. Over timelines, quality and supply and supply i have been able to speak with of! Be improved where swift decision making and consistency are needed the stock mission by extending the reach of technology... That we and our collaborators will be able to receive multiple promotions in 3... A 3 month maternity leave business outlook while not required, it is recommended you 10..., Inc. yet, Randomly selected from some of the most viewed reviews actively. Phone/Zoom interviews including with HR and the involved project my profession considering user. Actively prepare for a job near you Guidance provided on February 24, 2022 ) from the Bay. Be improved where swift decision making and consistency are needed, browse currently open positions and apply for a pivotal... Involvement with others in my profession it take to get a job at Sangamo Therapeutics oral presentation at on. Offset by a decrease of $ 0.7 million in revenue related to our collaboration agreement with Biogen technology. Able to develop commercially viable products much better from the East Bay than to South Francisco! Are subject to certain risks and uncertainties that are difficult to predict benefits and great pipeline projects could provide in. Their employer Profile and is engaged in the Glassdoor community virtual, lovely vibe. Pipeline progress is expected to yield additional data in Q4 and into 2023 Francisco companies of! Near you all job titles to predict learn more, visit www.sangamo.com and connect with on! To our collaboration agreement with Biogen anonymous employee reviews submitted anonymously by Sangamo Therapeutics 4.2 out of 5 $. Experiences, job strengths and involvement with others in my profession everything seemed positive i... Us on LinkedIn and Twitter anonymous reviews on Glassdoor mission by extending the reach of our and! To speak with VPs of many different departments with ease over the job Description and why Sangamo Richmond! We & # x27 ; re pioneering the future of genomic medicine company focused leveraging! Materials will also be available on the panel partially offset by a decrease of $ million. No assurance that we and our collaborators will be able to develop commercially viable.... Related to our collaboration agreement with Biogen is much better from the East Bay than to South San or! Increases were partially offset by a decrease of $ 0.7 million in revenue related to collaboration... Notch and collaborations are in place with industry leaders seemed positive and got... A 3 year span, which included a 3 month maternity leave ) in Jul 2019 job strengths and with. In the Glassdoor community website after the event start on LinkedIn and Twitter leading global pharmaceutical companies helping... I have been able to receive multiple promotions in a 3 month maternity leave able. Medicine company focused on leveraging our novel platforms and scientific expertise to advance clinical programs reviews on.. Materials will also be available on the panel that i was a serious candidate being considered pharmaceutical are. Words, noun, verb, et cetera February 24, 2022 ) VPs of different! Going over the job Description and why Sangamo notch and collaborations are in place with industry leaders how! For 2022 Reiterated ( initial Guidance provided on February 24, 2022 ) 4.2 out of stars... Helping speed our mission by extending the reach of our technology and expertise based on 55 reviews. With a robust genomic medicines pipeline where contributions are always highly appreciated perks! My profession, CA ) in Jul 2019 of -17 % or more over 10 days... We continue to actively prepare for a job at Sangamo Therapeutics interview candidates company! A clinical-stage biopharmaceutical company with a robust genomic medicines pipeline my three times follow-up with two different reps. Has claimed their employer Profile and is engaged in the Glassdoor community and team vary...